Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 3


Results: 12
    1
    2
    3
    4
    5
    6
    7
    8

    Targeting of the WT1 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination.

    Published in:
    Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 319, doi. 10.1007/s00262-016-1938-y
    By:
    • Dagvadorj, Nergui;
    • Deuretzbacher, Anne;
    • Weisenberger, Daniela;
    • Baumeister, Elke;
    • Trebing, Johannes;
    • Lang, Isabell;
    • Köchel, Carolin;
    • Kapp, Markus;
    • Kapp, Kerstin;
    • Beilhack, Andreas;
    • Hünig, Thomas;
    • Einsele, Hermann;
    • Wajant, Harald;
    • Grigoleit, Götz
    Publication type:
    Article
    9
    10
    11
    12

    Acknowledgement.

    Published in:
    Cancer Immunology, Immunotherapy, 2017, v. 66, n. 3, p. 411, doi. 10.1007/s00262-017-1956-4
    Publication type:
    Article